16-786047-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_058192.3(RPUSD1):c.842G>A(p.Arg281Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000448 in 1,518,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_058192.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPUSD1 | NM_058192.3 | c.842G>A | p.Arg281Gln | missense_variant | 6/6 | ENST00000007264.7 | NP_478072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPUSD1 | ENST00000007264.7 | c.842G>A | p.Arg281Gln | missense_variant | 6/6 | 2 | NM_058192.3 | ENSP00000007264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152130Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000442 AC: 7AN: 158486Hom.: 0 AF XY: 0.0000461 AC XY: 4AN XY: 86782
GnomAD4 exome AF: 0.0000359 AC: 49AN: 1366118Hom.: 0 Cov.: 31 AF XY: 0.0000418 AC XY: 28AN XY: 669820
GnomAD4 genome AF: 0.000125 AC: 19AN: 152130Hom.: 0 Cov.: 34 AF XY: 0.000135 AC XY: 10AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2022 | The c.842G>A (p.R281Q) alteration is located in exon 6 (coding exon 5) of the RPUSD1 gene. This alteration results from a G to A substitution at nucleotide position 842, causing the arginine (R) at amino acid position 281 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at